Sensei Biotherapeutics Q4 EPS $(3.74) Beats $(4.11) Estimate

Sensei Biotherapeutics (NASDAQ: SNSE) reported a Q4 loss of $(3.74) per share, which exceeded the analyst estimate of $(4.11) by 9%. This represents a 39.68% improvement compared to losses of $(6.20) per share in the same quarter last year.